Hirudin versus heparin for anticoagulation in continuous renal replacement therapy

Intensive Care Medicine

Volumn 27, Issue 4, 2001, Pages 673-679

  Vargas Hein, O ^a   Von Heymann, C ^a   Lipps, M ^a   Ziemer, S ^a   Ronco, C ^b   Neumayer, H H ^a   Morgera, S ^a   Welte, M ^a   Kox, W J ^a   Spies, C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Anticoagulation; Bleeding; Continuous haemofiltration; Critically ill patients; Efficacy; Heparin; Hirudin

Indexed keywords

HEPARIN; HIRUDIN; LEPIRUDIN; LIQUEMIN N;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING TIME; BLOOD FILTER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; FEMALE; HEMODIALYSIS; HUMAN; INTENSIVE CARE; MALE; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; APACHE; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; COMBINED MODALITY THERAPY; FEMALE; HEMORRHAGE; HEPARIN; HIRUDIN THERAPY; HIRUDINS; HUMANS; INTENSIVE CARE UNITS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; RENAL REPLACEMENT THERAPY;

EID: 0035052894     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340100907     Document Type: Article

References (30)

1. Risk factors and outcome of hospital acquired acute renal failure. Clinical epidemiological study
2. Hospital acquired renal insufficiency: A prospective study
3. Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes and hospital resource utilization
4. Initial versus delayed acute renal failure in the intensive care unit. A multicenter prospective epidemiological study
5. Kontinuierliche Dialyseverfahren bei akutem Nierenversagen
6. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial
7. Anticoagulant regimes in acute continuous hemodiafiltration: A comparative study
8. Maintaining blood flow in the extracorporeal circuit: Haemostasis and anticoagulation
9. Practical aspects of renal replacement therapy
10. Recombinant hirudin: A specific thrombin inhibiting anticoagulant for hemodialysis
11. A comparison between the use of recombinant hirudin and heparin during hemodialysis
12. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding
13. Heparin-induced thrombocytopenia
14. Heparin-induced thrombocytopenia: Pathogenesis, frequency, avoidance and management
15. Pharmacology of r-hirudin in renal impairment
16. Quantitative determination of hirudin in blood and body fluids
17. Hirudin elimination by hemofiltration: A comparative in vitro study of different membranes
18. Elimination von rekombinanten Hirudin aus der Blutzirkulation mittels Hämofiltration
19. Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis
20. Bleeding after intermittent or continuous r-hirudin during CVVH
21. Serious bleeding in a haemodialysis patient treated with recombinant hirudin
22. Monitoring of the action of antithrombin agents by ecarin clotting time
23. Anticoagulation strategies for continuous renal replacement therapies: What works?
24. The effect of r-hirudin vs. heparin on blood-membrane interactions during hemodialysis
25. Hemostatic alterations during continuous venovenous hemofiltration in acute renal failure
26. Heparin detection by activated coagulation time: A comparison of the sensitivity of coagulation tests and heparin assays
27. Alterations of clotting factors and platelets during hemofiltration
28. Influence of heparin and hirudin on endothelial binding of antithrombin in experimental thrombinemia
29. Monitoring of recombinant hirudin: Assessment of a plasma-based ecarin clotting time assay
30. Monitoring anticoagulant therapy by activated partial thromboplastin time: Hirudin assessment